Discover 1,944 paid clinical trials in Arlington, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,944
Active & Responsive
Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors
for
Advanced Solid Tumors, Metastatic Solid Tumors,
Location: Irving TX, Houston TX, San Antonio TX, St Louis MO,
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT07397338
Phase 1, Phase 2, Recruiting
Active & Responsive
A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001)
for
Malignant Neoplasm
Location: Irving TX, Fairfax VA, Toronto, New Brunswick NJ,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07247110
Phase 1, Recruiting
Active & Responsive
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
for
Prostate Cancer Castration-resistant Prostate Cancer,
Location: Irving TX, San Antonio TX, Grand Rapids MI,
Sponsor: MBrace Therapeutics
Sex: All
Age: 18+
Code: NCT07145255
Phase 1, Phase 2, Recruiting
Active & Responsive
A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors
for
Locally Advanced (Unresectable) or Metastatic Solid Tumors
Location: Dallas TX, Austin TX, Houston TX, San Antonio TX,
Sponsor: NEOK Bio, Inc.
Sex: All
Age: 18+
Code: NCT07612176
Phase 1, Recruiting
Active & Responsive
A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
for
Major Depressive Disorder (MDD), Depression in Adults,
Location: DeSoto TX, Houston TX, San Antonio TX, New Orleans LA,
Sponsor: Cybin IRL Limited
Sex: All
Age: 18 - 70+
Code: NCT06793397
Phase 3, Recruiting
Active & Responsive
NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
for
Major Depressive Disorder
Location: DeSoto TX, Bryant AR, Atlanta GA, Mason OH, Tampa FL,
Sponsor: Neurocrine Biosciences
Sex: All
Age: 18+
Code: NCT06911112
Phase 3, Recruiting
Active & Responsive
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)